Science & research

Hyperthermia + Immunotherapy

Current research focuses on combining hyperthermia with so-called „Immune check-point inhibitors”. Inhibitors of control points reduce the suppression of cytotoxic T lymphocytes and activate them to attack cancer cells. By. preclinical data: the effectiveness of T lymphocytes in attacking cancer cells is 3 times higher at 39.5 ° C than at 37 ° C.

HT Systems

Belgradzka street 5
02-793 Warszawa

+48 22 300 91 85

info@htsystems.com.pl

logo HT SYSTEMS

MODERN
MEDICINE IN FIGHT
WITH CANCER

Office hours:

Monday - Friday from 8:00 to 18:00